Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)

Published:2002-09-15 Issue:18 Volume:23 Page:1422-1432
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Moiseyev V

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/23/18/1422/17885235/1422.pdf

Cited by 488 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort;Archives of Cardiovascular Diseases;2024-08

2. Inotropic Agents: Are We Still in the Middle of Nowhere?;Journal of Clinical Medicine;2024-06-26

3. Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta‐analysis;ESC Heart Failure;2024-02-28

4. Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors;European Journal of Heart Failure;2024-02

5. Use of Inotropic Agents in Advanced Heart Failure: Pros and Cons;Cardiology;2024-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP